Oregon Public Employees Retirement Fund’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $254K | Buy |
3,886
+100
| +3% | +$6.53K | ﹤0.01% | 1333 |
|
2025
Q1 | $253K | Sell |
3,786
-100
| -3% | -$6.7K | ﹤0.01% | 1326 |
|
2024
Q4 | $215K | Hold |
3,886
| – | – | ﹤0.01% | 1393 |
|
2024
Q3 | $232K | Buy |
3,886
+200
| +5% | +$11.9K | ﹤0.01% | 1382 |
|
2024
Q2 | $235K | Sell |
3,686
-400
| -10% | -$25.5K | ﹤0.01% | 1356 |
|
2024
Q1 | $282K | Sell |
4,086
-368
| -8% | -$25.4K | 0.01% | 1335 |
|
2023
Q4 | $246K | Sell |
4,454
-300
| -6% | -$16.5K | ﹤0.01% | 1421 |
|
2023
Q3 | $276K | Buy |
4,754
+400
| +9% | +$23.2K | ﹤0.01% | 1486 |
|
2023
Q2 | $234K | Buy |
4,354
+300
| +7% | +$16.1K | ﹤0.01% | 1550 |
|
2023
Q1 | $161K | Sell |
4,054
-10
| -0.2% | -$397 | ﹤0.01% | 1618 |
|
2022
Q4 | $163K | Buy |
4,064
+55
| +1% | +$2.21K | ﹤0.01% | 1618 |
|
2022
Q3 | $129K | Sell |
4,009
-288
| -7% | -$9.27K | ﹤0.01% | 1631 |
|
2022
Q2 | $127K | Sell |
4,297
-481
| -10% | -$14.2K | ﹤0.01% | 1489 |
|
2022
Q1 | $134K | Buy |
4,778
+1,126
| +31% | +$31.6K | ﹤0.01% | 1665 |
|
2021
Q4 | $168K | Sell |
3,652
-200
| -5% | -$9.2K | ﹤0.01% | 1537 |
|
2021
Q3 | $126K | Hold |
3,852
| – | – | ﹤0.01% | 1554 |
|
2021
Q2 | $135K | Hold |
3,852
| – | – | ﹤0.01% | 1552 |
|
2021
Q1 | $139K | Buy |
3,852
+100
| +3% | +$3.61K | ﹤0.01% | 1564 |
|
2020
Q4 | $109K | Sell |
3,752
-60
| -2% | -$1.74K | ﹤0.01% | 1563 |
|
2020
Q3 | $108K | Hold |
3,812
| – | – | ﹤0.01% | 1510 |
|
2020
Q2 | $123K | Hold |
3,812
| – | – | ﹤0.01% | 1484 |
|
2020
Q1 | $155K | Hold |
3,812
| – | – | ﹤0.01% | 1398 |
|
2019
Q4 | $235K | Buy |
3,812
+400
| +12% | +$24.7K | ﹤0.01% | 1433 |
|
2019
Q3 | $249K | Buy |
3,412
+100
| +3% | +$7.3K | ﹤0.01% | 1475 |
|
2019
Q2 | $272K | Buy |
3,312
+100
| +3% | +$8.21K | ﹤0.01% | 1467 |
|
2019
Q1 | $227K | Buy |
3,212
+58
| +2% | +$4.1K | ﹤0.01% | 1490 |
|
2018
Q4 | $142K | Buy |
+3,154
| New | +$142K | ﹤0.01% | 1574 |
|